CoChat

Correction of Feline Lipoprotein Lipase Deficiency with Adeno-Associated Virus Serotype 1-Mediated Gene Transfer of the Lipoprotein Lipase S447X Beneficial Mutation

Ross, Colin J.D., Twisk, Jaap, Bakker, Andrew C., Miao, Fudan, Verbart, Dennis, Rip, Jaap, Godbey, Tamara, Dijkhuizen, Paul, Hermens, Wim T.J.M.C., Kastelein, John J.P., Kuivenhoven, Jan Albert, Meulenberg, Janneke M., Hayden, Michael R. · 2006 · Human Gene Therapy
Cited by 82

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Human lipoprotein lipase (hLPL) deficiency, for which there currently exists no adequate treatment, leads to excessive plasma triglycerides (TGs), recurrent abdominal pain, and life-threatening pancreatitis. We have shown that a single intramuscular administration of adeno-associated virus (AAV) serotype 1 vector, encoding the human LPL(S447X) variant, results in complete, long-term normalization of dyslipidemia in LPL(/) mice. As a prelude to gene therapy for human LPL deficiency, we tested the efficacy of AAV1-LPL(S447X) in LPL(/) cats, which demonstrate hypertriglyceridemia (plasma TGs, >10,000 mg/dl) and clinical symptoms similar to LPL deficiency in humans, including pancreatitis. Male LPL(/) cats were injected intramuscularly with saline or AAV1-LPL(S447X) (1 x 10(11)-1.7 x 10(12) genome copies [GC]/kg), combined with oral doses of cyclophosphamide (0-200 mg/m(2) per week) to inhibit an immune response against hLPL. Within 3-7 days after administration of >or=5 x 10(11) GC of AAV1-LPL(S447X) per kilogram, the visible plasma lipemia was completely resolved and plasma TG levels were reduced by >99% to normal levels (10-20 mg/dl); intermediate efficacy (95% reduction) was achieved with 1 x 10(11) GC/kg. Injection in two sites, greatly limiting the amount of transduced muscle, was sufficient to completely correct the dyslipidemia. By varying the dose per site, linear LPL expression was demonstrated over a wide range of local doses (4 x 10(10)-1 x 10(12) GC/site). However, efficacy was transient, because of an anti-hLPL immune response blunting LPL expression. The level and duration of efficacy were significantly improved with cyclophosphamide immunosuppression. We conclude that AAV1-mediated delivery of LPL(S447X) in muscle is an effective means to correct the hypertriglyceridemia associated with feline LPL deficiency.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/hum.2006.17.487

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 31

  1. 10.1182/blood-2003-05-1446 · DOI · Paper page
  2. BIJVOET S., 1996, J. Lipid Res., 37, 640, 10.1016/S0022-2275(20)37605-7 · DOI · Paper page
  3. 10.1038/sj.gt.3301024 · DOI
  4. 10.1006/mthe.2001.0449 · DOI · Paper page
  5. 10.1161/01.ATV.17.11.2532 · DOI
  6. 10.1006/mthe.2000.0032 · DOI · Paper page
  7. 10.1034/j.1399-0004.1999.550609.x · DOI · Paper page
  8. 10.1073/pnas.182412299 · DOI · Paper page
  9. 10.1172/JCI118541 · DOI · Paper page
  10. 10.1046/j.1365-2362.1999.00435.x · DOI · Paper page
  11. GOLDBERG I.J., 1996, J. Lipid Res., 37, 693, 10.1016/S0022-2275(20)37569-6 · DOI · Paper page
  12. 10.1161/01.CIR.95.12.2628 · DOI · Paper page
  13. 10.1073/pnas.94.11.5804 · DOI · Paper page
  14. 10.1038/73464 · DOI · Paper page
  15. 10.4049/jimmunol.166.10.6099 · DOI · Paper page
  16. 10.1089/10430340050016120 · DOI · Paper page
  17. 10.1002/jgm.686 · DOI · Paper page
  18. 10.1182/blood.V97.5.1258 · DOI · Paper page
  19. NIERMAN M.C., 2005, Neth. J. Med., 63, 14
  20. ORANJE P.P., 2004, Mol. Ther., 9, S162
  21. 10.1089/hum.2005.16.1276 · DOI · Paper page
  22. 10.1089/hum.2004.15.906 · DOI · Paper page
  23. 10.1128/JVI.75.1.269-277.2001 · DOI · Paper page
  24. 10.1002/jgm.175 · DOI · Paper page
  25. 10.1073/pnas.95.24.14384 · DOI · Paper page
  26. 10.1074/jbc.M104430200 · DOI · Paper page
  27. 10.1089/104303402760128577 · DOI · Paper page
  28. 10.1073/pnas.96.7.3906 · DOI · Paper page
  29. 10.1038/sj.gt.3302539 · DOI
  30. 10.1182/blood-2004-03-0848 · DOI · Paper page
  31. WATSON T.D., 1995, Am. J. Vet. Res., 56, 289, 10.2460/ajvr.1995.56.03.289 · DOI

Cited by

See all 82

Metadata

Authors
Ross, C. J. D., Twisk, J., Bakker, A. C., Miao, F., Verbart, D., Rip, J., Godbey, T., Dijkhuizen, P., Hermens, W. T. J. M. C., Kastelein, J. J. P., Kuivenhoven, J. A., Meulenberg, J. M., & Hayden, M. R.
Venue
Human Gene Therapy
Published
2006-05
Volume
17
Issue
5
Pages
487-499
ISSN
  • 1043-0342 (ISSN-L)
  • 1557-7422
OpenAlex
W2025763389
Cited by
82
References
9
Type
journal article
Language
en
Open access
closed
Licence
www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.